LON:ODX Omega Diagnostics Group (ODX) Share Forecast, Price & News GBX 2.65 0.00 (0.00%) (As of 06/9/2023 ET) Add Compare Share Share Today's Range 2.55▼ 2.7450-Day Range 2.40▼ 3.1052-Week Range 2.12▼ 4.50Volume238,656 shsAverage Volume924,293 shsMarket Capitalization£6.30 millionP/E RatioN/ADividend YieldN/APrice TargetN/A ProfileProfileChartCompetitorsInsider TradesHeadlinesProfileChartCompetitorsInsider TradesHeadlines About Omega Diagnostics Group (LON:ODX) StockOmega Diagnostics Group PLC, through its subsidiaries, develops, manufactures, and distributes medical diagnostics products in the United Kingdom, rest of Europe, North America, South/Central America, India, other Asian countries and the Far East, Africa, and the Middle East. The company is also involved in the research, development, and production of kits, as well as engaged in detection of immune reactions to food under the Foodprint name. It provides clinical analysis to the general public, clinics, and health professionals, as well as supplies Food Detective, a consumer food test. The company serves government, private hospitals, reference laboratories, nutritionists, naturopaths, and other healthcare professionals. It markets its products approximately in 70 countries worldwide. Omega Diagnostics Group PLC was founded in 1987 and is based in Alva, the United Kingdom.Read More Receive ODX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Omega Diagnostics Group and its competitors with MarketBeat's FREE daily newsletter. Email Address ODX Stock News HeadlinesMay 11, 2023 | americanbankingnews.comChristopher Paul Lea Acquires 69,498 Shares of Omega Diagnostics Group PLC (LON:ODX) StockApril 17, 2023 | marketwatch.comOmega Diagnostics Sees Widened FY 2023 Ebitda Loss on Lower Production YieldsJune 10, 2023 | Behind the Markets (Ad)The single greatest medical breakthrough of all time?We are on the cusp of a medical breakthrough. And soon, this single breakthrough could lead to the cure of over 6,000 genetic diseases, including Alzheimer's, heart disease, and even cancer! This reminds me of Amgen, where early investors made as much as 46,751% when they released their revolutionary drug to the market.January 18, 2023 | marketwatch.comOmega Diagnostics Shares Fall as Revenue Delays Hit FY 2023 PerformanceJanuary 18, 2023 | markets.businessinsider.comOmega Diagnostics Sees EBITDA Loss In FY; Unable To Fulfil Current Orders Before Year End October 26, 2022 | marketwatch.comOmega Diagnostics Continues to See FY in Line With Market ViewsOctober 5, 2022 | marketwatch.comOmega Diagnostics Shares Rise After WHO's Positive Draft Report on Disease's TestAugust 26, 2022 | yahoo.comOmega Venture Partners Announces Four New Investments and Honored as Best Technology VC FirmJune 10, 2023 | Behind the Markets (Ad)The single greatest medical breakthrough of all time?We are on the cusp of a medical breakthrough. And soon, this single breakthrough could lead to the cure of over 6,000 genetic diseases, including Alzheimer's, heart disease, and even cancer! This reminds me of Amgen, where early investors made as much as 46,751% when they released their revolutionary drug to the market.August 3, 2022 | msn.comOmega Diagnostics sells testing business for £6.1m to Chinese-owned firm that bought Alva siteApril 7, 2022 | proactiveinvestors.com.auOmega Diagnostics hails Health & Nutrition revenue growth as Covid-related revenues witherMarch 11, 2022 | marketwatch.comOmega Diagnostics' Visitect Covid-19 Antigen Test Rejected for Approval by UK Health Security AgencyMarch 11, 2022 | proactiveinvestors.com.auDeepVerge reports record quarter for environmental divisionMarch 11, 2022 | proactiveinvestors.com.auOmega Diagnostics gets negative result for COVID test kit with UK Health Security AgencyMarch 11, 2022 | reuters.comOmega Diagnostics' COVID test rejected for sale in UK; shares fallMarch 7, 2022 | marketwatch.comOmega Diagnostics' Fund Raising Was Rejected by Shareholders; Shares RiseFebruary 12, 2022 | lse.co.ukOmega shares down on discounted fundraise; sells Alva facilityFebruary 10, 2022 | marketwatch.comOmega Diagnostics Confirms It Is Considering Fund RaisingJanuary 20, 2022 | marketwatch.comOmega Diagnostics' CEO Steps Down; Jag Grewal Appointed SuccessorDecember 14, 2021 | marketwatch.comOmega Diagnostics Says Covid-19 Antigen Test Performs With High Accuracy on Omicron VariantNovember 25, 2021 | marketwatch.comOmega Diagnostics Shares Fall on Widened 1H Loss, Expired UK Government ContractNovember 23, 2021 | finance.yahoo.comHere's Why We're Watching Omega Diagnostics Group's (LON:ODX) Cash Burn SituationNovember 1, 2021 | marketwatch.comOmega Diagnostics Shares Rise on Partnership Agreement With DAM HealthSeptember 24, 2021 | finance.yahoo.comInvesting in Omega Diagnostics Group (LON:ODX) three years ago would have delivered you a 230% gainAugust 26, 2021 | fool.co.ukWhy has the ODX share price climbed 25% in 3 days?July 27, 2021 | marketwatch.comOmega Diagnostics's AbC-19 Lateral Flow Covid-19 Test Got Positive ReviewJuly 26, 2021 | finance.yahoo.comWhat You Need To Know About Omega Diagnostics Group PLC's (LON:ODX) Investor CompositionSee More Headlines ODX Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart Industry, Sector and Symbol Stock ExchangeLON Industry Medical Instruments & Supplies Sub-IndustryN/A SectorMedical Current SymbolLON:ODX CUSIPN/A CIKN/A Webwww.omegadiagnostics.com Phone+44-1259-763030FaxN/AEmployees85Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)GBX (0.02) Trailing P/E RatioN/A Forward P/E Ratio104.95 P/E GrowthN/ANet Income£-2,760,000.00 Net Margins-136.70% Pretax MarginN/A Return on Equity-17.04% Return on Assets-3.44% Debt Debt-to-Equity Ratio1.14 Current Ratio3.70 Quick Ratio3.31 Sales & Book Value Annual Sales£7.81 million Price / Sales0.81 Cash FlowGBX 0.88 per share Price / Cash Flow3.00 Book ValueGBX 5 per share Price / Book0.53Miscellaneous Outstanding Shares237,680,000Free FloatN/AMarket Cap£6.30 million OptionableNot Optionable Beta3.99 Key ExecutivesMr. Jagdeep Grewal B.Sc. (Age 54)M.B.A., M.Sc., CEO & Exec. Director Comp: $174kMr. Christopher Paul Lea A.C.A. (Age 56)B.Sc., CFO, Company Sec. & Director Comp: $186.68kMr. Iain LoganGroup Financial ControllerMr. Prashant ManiarManaging Director of Omega Dx Asia Pvt LimitedMr. Andrew William Shepherd (Age 67)Global Ambassador - Life Pres Key CompetitorsAkers BiosciencesLON:AKRAptamer GroupLON:APTACellular GoodsLON:CBXYourgene HealthLON:YGENOvoca BioLON:OVBView All CompetitorsInsidersChristopher Paul LeaBought 69,498 shares on 5/5/2023Total: £208,494.00 ($3.00/share)Jag GrewalBought 1,000,000 shares on 1/26/2023Total: £3 M ($3.00/share)Christopher Paul LeaBought 65,454 shares on 11/7/2022Total: £196,362.00 ($3.00/share)Christopher Paul LeaBought 400,000 shares on 9/15/2022Total: £1.20 M ($3.00/share)View All Insider Transactions ODX Stock - Frequently Asked Questions How have ODX shares performed in 2023? Omega Diagnostics Group's stock was trading at GBX 3.75 at the beginning of 2023. Since then, ODX shares have decreased by 29.3% and is now trading at GBX 2.65. View the best growth stocks for 2023 here. What other stocks do shareholders of Omega Diagnostics Group own? Based on aggregate information from My MarketBeat watchlists, some companies that other Omega Diagnostics Group investors own include CAP-XX (CPX), NVIDIA (NVDA), Tiziana Life Sciences (TILS), Velocys (VLS), Advanced Micro Devices (AMD), COSCO SHIPPING (CICOF), Co-Diagnostics (CODX), 4D pharma (DDDD) and Datadog (DDOG). What is Omega Diagnostics Group's stock symbol? Omega Diagnostics Group trades on the London Stock Exchange (LON) under the ticker symbol "ODX." How do I buy shares of Omega Diagnostics Group? Shares of ODX stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.Compare Top Brokerages Here. What is Omega Diagnostics Group's stock price today? One share of ODX stock can currently be purchased for approximately GBX 2.65. How much money does Omega Diagnostics Group make? Omega Diagnostics Group (LON:ODX) has a market capitalization of £6.30 million and generates £7.81 million in revenue each year. The company earns £-2,760,000.00 in net income (profit) each year or GBX (0.02) on an earnings per share basis. How can I contact Omega Diagnostics Group? Omega Diagnostics Group's mailing address is Hillfoots Business Village Alva Industrial Estate, ALVA, FK12 5DQ, United Kingdom. The official website for the company is www.omegadiagnostics.com. The company can be reached via phone at +44-1259-763030. This page (LON:ODX) was last updated on 6/10/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Omega Diagnostics Group PLC Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.